TIA: Clinical Trials

5 trials for TIA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 3, Completed 2
Phase 32Unknown 2

Follow TIA: new trials by email Literature Review of TIA trials Research Report on TIA

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
Ferrous succinate - Vascular Cognitive Impairment, Dementia, Vascular
Phase 2UnknownBeijing Tiantan Hospital10062019-04-012020-07-13
Personalized Antiplatelet Secondary Stroke PRevenTion
tailored antiplatelet selection, standard of care - Ischemic Stroke, TIA
Phase 2CompletedState University of New York - Upstate Medical University902018-06-112023-12-15
Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
Apixaban, Clopidogrel, Aspirin - Ischemic Stroke, TIA
Phase 2 / Phase 3UnknownXijing Hospital100002014-01-012013-08-16
Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events
rivaroxaban, Aspirin, placebo - Ischemic Stroke, TIA
Phase 2 / Phase 3UnknownXijing Hospital37002013-09-012013-08-16
Revacept in Symptomatic Carotid Stenosis
Revacept, Placebo - Carotid Stenosis, Atherosclerosis
Phase 2CompletedAdvanceCor GmbH1582013-03-082021-01-28

Narrower conditions

Ischemic Stroke (3)  ·  Amaurosis Fugax (1)  ·  Anemia, Iron-Deficiency (1)  ·  Atherosclerosis (1)  ·  Carotid Stenosis (1)  ·  Cerebral Infarction (1)  ·  Dementia (1)  ·  Dementia, Vascular (1)  ·  Iron Deficiencies (1)  ·  Ischemic Attack, Transient (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (5)  ·  Cardiovascular Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Cerebrovascular Disorders (5)  ·  Nervous System Diseases (5)  ·  Vascular Diseases (5)  ·  Stroke (4)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Brain Ischemia (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Anemia (1)  ·  Anemia, Hypochromic (1)  ·  Blindness (1)  ·  Brain Infarction (1)

Interventions

Aspirin (2)  ·  Clopidogrel (1)  ·  Control Groups (1)  ·  Revacept (1)  ·  Rivaroxaban (1)  ·  Standard of Care (1)  ·  apixaban (1)  ·  ferrous succinate (1)

Sponsors

Xijing Hospital (2)  ·  AdvanceCor GmbH (1)  ·  Beijing Tiantan Hospital (1)  ·  State University of New York - Upstate Medical University (1)

Countries

China (3)  ·  Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Gang Zhao, M.D. (2)  ·  Holger Poppert, Prof. Dr. (1)  ·  Ian M Loftus, MD (1)  ·  Jia Qian, doctor (1)  ·  Karen C Albright, PhD, DO (1)

Results publications

PMID 26458895, PMID 35695006, PMID 38789134